AMSBIO: Adeno-Associated Virus Services for Gene Delivery

AMSBIO has introduced an expanded range of Adeno-associated virus (AAV) cloning and packaging services.

Adeno-associated viruses are single-stranded DNA viruses that can infect a broad range of cell types including dividing and non-dividing cells and are, therefore, widely used vehicles for gene delivery. Clinical trials have not only found AAV to be consistently safe and stable, but their vectors are capable of causing long-term expression in human cells. Therefore, AAV vectors have many advantages that many other vectors do not. To date, recombinant AAV (rAAV) vectors have been used in many clinical trials in gene therapy, and have achieved promising results from Phase 1 and Phase 2 trials.

AMSBIO offers the highest quality rAAV vectors and the most complete AAV Expression Systems that can be used to express shRNA, or human ORF. Through proprietary technology and innovative AAV vectors, AMSBIO is able to deliver reliable, reproducible, high purity, high titre viral stock every time. AMSBIO AAV vectors do not elicit significant immune response in vivo and therefore can be used for in vivo gene deliveries. Working with AMSBIO AAV vectors saves you time and increases your efficiency at a cost-effective price.

AMSBIO has also established a robust and professional AAV packaging service, ranging from the small crude scale to the large purified scale.  Drawing upon its considerable experience and expertise AMSBIO is able to provide a platform that suits all your needs when it comes to combining scientific discovery and processing advancements in the field of gene therapy. With AMSBIO's production system, using AAV as a therapeutic vehicle for a broad range of diseases is now a simple task.

For further information please visit http://www.amsbio.com/adeno-associated_virus.aspx or contact AMSBIO on +44-1235-828200 / +1-617-945-5033 / info@amsbio.com.

Founded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries. AMSBIO is able to draw upon in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. Widely acknowledged as an expert in cell culture, AMSBIO partners with clients in tailoring cell systems to enhance organoid and spheroid type screening outcomes from a technological and cost-effective perspective. Custom services include stable cell line production, CRISPR/Cas9 Genome Editing, lentivirus and adenovirus production, large scale protein production and a comprehensive portfolio of antibody services.

---------------------

Worldwide HQ 

AMS Biotechnology (AMSBIO)

184 Milton Park
Abingdon

Oxon OX14 4SE

UK

Tel: +44-1235-828200
Fax: +44-1235-820482
Email: info@amsbio.com 
Web www.amsbio.com

 

 

North American HQ

 

AMSBIO LLC
1035 Cambridge Street
Cambridge
MA 02141
USA

Tel:      +1.617.945.5033 
Tel:      +1.800.987.0985 (toll free)
Email: info@amsbio.com 
Web www.amsbio.com